Nur77 Prevents Osteoporosis by Inhibiting the NF-κB Signalling Pathway and Osteoclast Differentiation

Huanlian Tian1,2, Feng Chen1, Yingfang Wang3

  • 1Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.

Insights

Nuclear receptor 77 (Nur77) inhibits osteoclast differentiation and bone loss by suppressing the NF-κB pathway. Nur77 shows potential for preventing and treating osteoporosis by reducing inflammation.

Area of Science:

  • Molecular Biology
  • Immunology
  • Bone Biology

Background:

  • Inflammation is a key risk factor for osteoporosis.
  • Nuclear receptor 77 (Nur77) has known anti-inflammatory roles, but its function in osteoporosis is uncharacterized.

Purpose of the Study:

  • To investigate the osteoprotective and anti-inflammatory effects of Nur77 in osteoporosis.
  • To elucidate the molecular mechanisms underlying Nur77's role in bone metabolism.

Main Methods:

  • Utilized a knockout mouse model (Nur77 knockout) for in vivo studies.
  • Employed microCT, H&E staining, ELISA, and Western blotting for molecular analysis.
  • Conducted in vitro experiments using RAW264.7 cells to study osteoclast differentiation and inflammatory pathways.

Main Results:

  • Nur77 knockout accelerated femoral bone loss and increased serum levels of hsCRP and IL-6.
  • Knockout mice exhibited elevated expression of NF-κB, IL-6, TNF-α, and osteoclastogenesis factors.
  • Nur77 inhibited osteoclast differentiation by inducing IκB-α and suppressing IKK-β, thereby dampening the NF-κB signaling pathway.

Conclusions:

  • Nur77 suppresses osteoclast differentiation and bone loss by inhibiting the NF-κB signaling pathway.
  • Nur77 demonstrates significant potential as a therapeutic target for preventing and treating osteoporosis.
  • Elevated hsCRP levels are associated with an increased likelihood of osteoporosis in older adults.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.3K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.8K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.1K